
Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin
2014; American Society for Microbiology; Volume: 58; Issue: 4 Linguagem: Inglês
10.1128/aac.02189-13
ISSN1098-6596
AutoresFernando César Bizerra, Cristina Jiménez‐Ortigosa, Ana Carolina Remondi Souza, Giovanni Luís Breda, Flávio Queiroz‐Telles, David S. Perlin, Arnaldo Lopes Colombo,
Tópico(s)Peptidase Inhibition and Analysis
ResumoWe identified a case of breakthrough candidemia in a 25-year-old patient receiving micafungin prophylaxis (50 mg/day). Five Candida glabrata isolates were obtained from blood cultures and were classified as multidrug-resistant isolates, since all of them exhibited high MICs for echinocandin and azole drugs. A mutation (S663F) in hot spot 1 of the FKS2 gene was found in all five isolates. This mutation yielded a 1,3-β-D-glucan synthase enzyme with highly reduced sensitivities to echinocandin drugs.
Referência(s)